Each year, an estimated 7.9 million babies worldwide are born with birth defects, many of which appear healthy at birth and come from families with no history of the disorder. Many affected babies are not identified until the appearance of severe and often irreversible symptoms later in life.

Detecting a disease at an early stage can enable appropriate and timely medical intervention before more serious and sometimes irreversible health issues are caused.

BGI’s NOVA™ Newborn Genetic Screening is suitable for:

• Parents who want a comprehensive genetic screen for their baby
• Parents who would like to learn their baby’s drug-related genetic status
• Babies who have missed out on regular screening
• Babies from parents with a family history of inherited disorders or from a population identified as at higher risk for genetic disease